Developing a Qualification and Verification Strategy for Digital Tissue Image Analysis in Toxicological Pathology.

artificial intelligence digital pathology histopathology image analysis quality control whole slide images

Journal

Toxicologic pathology
ISSN: 1533-1601
Titre abrégé: Toxicol Pathol
Pays: United States
ID NLM: 7905907

Informations de publication

Date de publication:
06 2021
Historique:
pubmed: 30 12 2020
medline: 19 8 2021
entrez: 29 12 2020
Statut: ppublish

Résumé

Digital tissue image analysis is a computational method for analyzing whole-slide images and extracting large, complex, and quantitative data sets. However, as with any analysis method, the quality of generated results is dependent on a well-designed quality control system for the entire digital pathology workflow. Such system requires clear procedural controls, appropriate user training, and involvement of specialists to oversee key steps of the workflow. The toxicologic pathologist is responsible for reporting data obtained by digital image analysis and therefore needs to ensure that it is correct. To accomplish that, they must understand the main parameters of the quality control system and should play an integral part in its conception and implementation. This manuscript describes the most common digital tissue image analysis end points and potential sources of analysis errors. In addition, it outlines recommended approaches for ensuring quality and correctness of results for both classical and machine-learning based image analysis solutions, as adapted from a recently proposed Food and Drug Administration regulatory framework for modifications to artificial intelligence/machine learning-based software as a medical device. These approaches are beneficial for any type of toxicopathologic study which uses the described end points and can be adjusted based on the intended use of the image analysis solution.

Identifiants

pubmed: 33371797
doi: 10.1177/0192623320980310
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

773-783

Auteurs

Aleksandra Zuraw (A)

Pathology Department, 25913Charles River Laboratories, Frederick, MD, USA.

Michael Staup (M)

Pathology Department, 25913Charles River Laboratories, Durham, NC, USA.

Robert Klopfleisch (R)

Institute of Veterinary Pathology, 9166Freie Universität, Berlin, Germany.

Famke Aeffner (F)

Amgen Research, Translational Safety and Bioanalytical Sciences, Amgen Inc, South San Francisco, CA, USA.

Danielle Brown (D)

Pathology Department, 25913Charles River Laboratories, Durham, NC, USA.

Thomas Westerling-Bui (T)

Aiforia Inc, Cambridge, MA, USA.

Daniel Rudmann (D)

Pathology Department, 25913Charles River Laboratories, Ashland, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH